Dolutegravir Loaded Solid Self-Micro-Emulsifying Drug Delivery System for Enhanced Solubility and Dissolution
Abstract
Dolutegravir sodium (DG) is a recently approved antiretroviral drug belonging to BCS class II having poor aqueous solubility and only 16% oral bioavailability. Hence aim of the present work was to develop solid self micro-emulsifying drug delivery system (S-SMEDDS) of Dolutegravir for enhanced solubility and dissolution behaviour. Initially, solubility of DG was checked to select oil, surfactant, and co-surfactant. Pseudo ternary phase diagram was constructed to identify microemulsion region. Liquid SMEDDS of DG were prepared using Campul MCM, Tween 80 and Transcutol P as oil, surfactant, and co-surfactant, respectively. The effect of different oil, surfactant and co-surfactant concentrations on particle size, zeta potential and %transmittance was studied using Box–Behnken factorial design. The obtained liquid SMEDDS was evaluated for its thermodynamic stability, globule size, robustness to dilution, viscosity, dye solubilization test, cloud point, etc. Satisfactory formulations of liquid SMEDDS were converted to solid form by adsorption technique using Neusilin US2 as a solid carrier. Evaluation of S-SMEDDS showed that solubility of DG in S-SMEDDS increases from 0.270 to 33.52 mg/mL. In-vitro drug release of S-DG4 showed 99.86 ± 1.47% drug release within 120 minutes while plain DG showed 32.55 ± 1.52%. Hence study revealed that S-SMEDDS is a promising approach to enhance solubility, dissolution and hence bioavailability of poorly aqueous soluble drug like DG.
Keywords:
Dolutegravir, Solubility, Oral bioavailability, Self-emulsifying microemulsions, Campul MCM, Tween 80 and Transcutol PDOI
https://doi.org/10.25004/IJPSDR.2023.150207References
Alshehri S, Imam SS, Hussain A, Altamimi MA, Alruwaili NK, Alotaibi F et al. Potential of solid dispersions to enhance solubility, bioavailability, and therapeutic efficacy of poorly water-soluble drugs: newer formulation techniques, current marketed scenario and patents. Drug Deliv. 020;27(1):1625-43. Available from: doi:10.1080/10717544.2020.1846638, PMID 33207947.
Sareen S, Mathew G, Joseph L. Improvement in solubility of poor water-soluble drugs by solid dispersion. Int J Pharm Investig. 2012;2(1):12-7. Available from: doi: 10.4103/2230-973X.96921, PMID 23071955.
Shiundu KA. Assessment of the clinical effectiveness of dolutegravir based antiretroviral therapy among adults living with HIV at the Kenyatta National Hospital ([doctoral dissertation]. University of Nairobi).
Kandel CE, Walmsley SL. Dolutegravir–a review of the pharmacology, efficacy, and safety in the treatment of HIV. Drug Des Dev Ther. 2015;9:3547-55. Available from: doi: 10.2147/DDDT.S84850, PMID 26185421.
Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother. 2004;58(3):173-82. Available from: doi: 10.1016/j.biopha.2004.02.001, PMID 15082340.
Parmar K, Patel J, Sheth N. Self nano-emulsifying drug delivery system for embelin: design, characterization and in-vitro studies. Asian J Pharm Sci. 2015;10(5):396-404. Available from: doi: 10.1016/j.ajps.2015.04.006.
Jaiswal P, Aggrewal G, Kaur A. Bioavailability enhancement of poorly soluble drugs by SMEDDS- A review. J Drug Deliv Ther. 2013;3(1):98-109.
Shukla JB, Koli AR, Ranch KM, Parikh RK. Self microemulsifying drug delivery system. Int J Pharm Pharm Sci. 2010;1(2):13-33.
Bandivadekar MM, Pancholi SS, Shelke N. Preparation and characterization of solid SMEDDS by adsorbent techniques to improve dissolution profile of poorly aqueous soluble drug ramipril. Int Res J Pharm. 2011;2(6):85-90.
Yeom DW, Son HY, Kim JH, Kim SR, Lee SG, Song SH et al. Development of a solidified self-microemulsif ying drug delivery system (S-SMEDDS) for atorvastatin calcium with improved dissolution and bioavailability. Int J Pharm. 2016 Jun 15;506(1-2):302-11. Available from: doi: 10.1016/j.ijpharm.2016.04.059, PMID 27125455.
Dumpala RL, Khodakiya A. Formulation and statistical optimization of S-SMEDDS of nicardipine hydrochloride by using BBD and PCA design. Int J Pharm Sci Res. 2021;12(3):1860-74. Available from: doi: 10.13040/IJPSR.0975-8232.12(3).1860-74.
Yuan Y, Li SM, Mo FK, Zhong DF. Investigation of microemulsion system for transdermal delivery of meloxicam. Int J Pharm. 2006;321(1-2):117-23. Available from: doi: 10.1016/j.ijpharm.2006.06.021, PMID 16876972.
Singh MK, Chandel V, Gupta V, Ramteke S. Formulation development and characterization of microemulsion for topical delivery of glipizide. Pharm Lett. 2010;2(3):33-42.
Mandal S, Mandal SS. Research paper microemulsion drug delivery system: a platform for improving dissolution rate of poorly water soluble drug. Int J PharmSci Nanotechnol. 2011;3(4):1214-9.
Kang BK, Lee JS, Chon SK, Jeong SY, Yuk SH, Khang G et al. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm. 2004;274(1-2):65-73. Available from: doi:10.1016/j.ijpharm.2003.12.028, PMID 15072783.
Cho HJ, Lee DW, Marasini N, Poudel BK, Kim JH, Ramasamy T et al. Optimization of self-microemulsifying drug delivery system for telmisartan using Box–Behnken design and desirability function. J Pharm Pharmacol. Available from: doi: 10.1111/jphp.12115, PMID 24028611.
Shafiq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, Ali M. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm. 2007;66(2):227-43. Available from: doi: 10.1016/j.ejpb.2006.10.014, PMID 17127045.
Bhagwat DA, Souza JI. Formulation and evaluation of solid self micro emulsifying drug delivery system using Aerosil 200 as solid carrier. Int Curr Pharm J. 2012;1(12):414-9. Available from: doi: 10.3329/icpj.v1i12.12451.
Khoo SM, Humberstone AJ, Porter CJH, Edwards GA, Charman WN. Formulation design and bioavailability assessment of lipidic selfemulsifying formulations of halofantrine. Int J Pharm. 1998;167(1-2):155-64. Available from: doi: 10.1016/S0378-5173(98)00054-4.
Bhagwat DA, Swami PA, Nadaf SJ, Choudhari PB, Kumbar VM, More HN et al. Capsaicin loaded solid SNEDDS for enhanced bioavailability and anticancer activity: in-vitro, in-silico, and in-vivo characterization. J Pharm Sci. 2021;110(1):280-91. Available from: doi: 10.1016/j.xphs.2020.10.020, PMID 33069713.
Patel PV, Patel HK, Panchal SS, Mehta TA. Self micro-emulsifying drug delivery system of tacrolimus: formulation, in vitro evaluation and stability studies. Int J Pharm Investig. 2013;3(2):95-104. Available from: doi: 10.4103/2230-973X.114899, PMID 24015381.
Dixit AR, Rajput SJ, Patel SG. Preparation and bioavailability assessment of SMEDDS containing valsartan. AAPS PharmSciTech. 2010;11(1):314-21. Available from: doi: 10.1208/s12249-010-9385-0, PMID 20182825.
Cho W, Kim MS, Kim JS, Park J, Park HJ, Cha KH et al. Optimized formulation of solid self-microemulsifying sirolimus delivery systems. Int J Nanomedicine. 2013;8:1673-82. Available from: doi: 10.2147/IJN.S43299, PMID 23641156.
Kim DS, Cho JH, Park JH, Kim JS, Song ES, Kwon J et al. Selfmicroemulsifying drug delivery system (SMEDDS) for improved oral delivery and photostability of methotrexate. Int J Nanomedicine. 2019;14:4949-60. Available from: doi: 10.2147/IJN.S211014, PMID 31308665.
Gupta S, Chavhan S, Sawant KK. Self-nanoemulsifying drug delivery system for adefovir dipivoxil: design, characterization, in vitro and ex vivo evaluation. Colloids Surf A Physicochem Eng Aspects. 2011;392(1):145-55. Available from: doi: 10.1016/j.colsurfa.2011.09.048.
Akula S, Gurram AK, Devireddy SR. Self-microemulsifying drug delivery systems: an attractive strategy for enhanced therapeutic profile. Int Sch Res Not. 2014;2014:964051. Available from: doi:10.1155/2014/964051, PMID 27382619.
Gumaste SG, Dalrymple DM, Serajuddin AT. Development of solid SEDDS, V: compaction and drug release properties of tablets prepared by adsorbing lipid-based formulations onto Neusilin® US2. Pharm Res. 2013;30(12):3186-99. Available from: doi: 10.1007/s11095-013-1106-4, PMID 23797463.
Bakhle SS. Development and evaluation of liquid and solid selfmicroemulsifying drug delivery system of lovastatin. Asian J Pharm (AJP). 2016;10(1).
Sundeep M, Vidyadhara S, Sailaja Y, Sandeep D, Sasidhar RL Ramu A. Formulation and evaluation of dolutegravir sodium solid dispersions and fast dissolving tablets using poloxamer-188 and jack fruit seed starch as excipients. Asian J Pharm Clin Res. 2019;12:1-0.
Chaudhary S, Nair AB, Shah J, Gorain B, Jacob S, Shah H et al. Enhanced solubility and bioavailability of dolutegravir by solid dispersion method: in vitro and in vivo evaluation—A potential approach for HIV therapy. AAPS PharmSciTech. 2021;22(3):127. Available from: doi: 10.1208/s12249-021-01995-y, PMID 33835317.
Aulton ME, Taylor K. Pharmaceutics-the science of dosage form design. London, England: Churchill Livingstone; 2002. p. 133-4.
Čerpnjak K, Zvonar A, Vrečer F, Gašperlin M. Development of a solid self-microemulsifying drug delivery system (SMEDDS) for solubility enhancement of naproxen. Drug Dev Ind Pharm. 2015;41(9):1548-57. Available from: doi: 10.3109/03639045.2014.971031, PMID 25308746.
Mulak UA, Narkhede SP, Shinde MP. Development of analytical method for in-vitro drug dissolution study of dolutegravir marketed formulation. J Pharm Sci Res. 2018 Nov 1;10(11):2726-30.
Pouton CW. Formulation of self-emulsifying drug delivery systems. Adv Drug Deliv Rev. 1997 Apr 14;25(1):47-58. Available from: doi:10.1016/S0169-409X(96)00490-5.
Cherniakov I, Domb AJ, Hoffman A. Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects. Expert Opin Drug Deliv. 2015;12(7):1121-33. Available from: doi: 10.1517/17425247.2015.999038, PMID 25556987.
Published

